YARROW BIOSCIENCE, INC. Increase (Decrease) in Accounts Payable
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Accounts Payable of $481.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2019-12-31 was $779.00K, a 33.16% increase year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2019-09-30 was -$1.71M.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2019-06-30 was $921.00K, a 42.04% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2019-03-31 was $493.00K, a 52.55% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2019 was $481.00K, a 41.70% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2018 was $825.00K, a 33.06% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2017 was $620.00K, a 30.26% decline from fiscal 2016.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2016 was $889.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2019-12-31 | $779.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$933.00K derived: sum of 2 quarters · filed 2020-03-03 | -$12.00K derived: sum of 3 quarters · filed 2020-03-03 | $481.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$791.00K derived: sum of 2 quarters · filed 2019-10-31 | -$298.00K 10-Q · filed 2019-10-31 | $287.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-06-30 | $921.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.41M 10-Q · filed 2019-08-01 | $2.00M derived: sum of 3 quarters · filed 2020-03-03 | -$389.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-03-31 | $493.00K 10-Q · filed 2019-05-02 | $1.08M derived: sum of 2 quarters · filed 2020-03-03 | -$1.31M derived: sum of 3 quarters · filed 2020-03-03 | $279.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-12-31 | $585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$1.80M derived: sum of 2 quarters · filed 2020-03-03 | -$214.00K derived: sum of 3 quarters · filed 2020-03-03 | $825.00K 10-K · filed 2020-03-03 |
| 2018-09-30 | -$2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$799.00K derived: sum of 2 quarters · filed 2019-10-31 | $240.00K 10-Q · filed 2019-10-31 | -$1.14M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.63M 10-Q · filed 2019-08-01 | $1.25M derived: sum of 3 quarters · filed 2020-03-03 | $2.77M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $1.04M 10-Q · filed 2019-05-02 | -$342.00K derived: sum of 2 quarters · filed 2020-03-03 | $1.18M derived: sum of 3 quarters · filed 2020-03-03 | $1.96M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $143.00K derived: sum of 2 quarters · filed 2020-03-03 | $923.00K derived: sum of 3 quarters · filed 2020-03-03 | $620.00K 10-K · filed 2020-03-03 |
| 2017-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.30M derived: sum of 2 quarters · filed 2018-11-07 | $2.00M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $780.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $477.00K 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | -$303.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $889.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |